基于两阶段DEA模型的我国医药制造业技术创新效率评价  

Evaluation on Technological Innovation Efficiency of Pharmaceutical Manufacturing Industry in China Based on Two-stage DEA Model

作　　者：徐玉萍 徐文 Xu Yuping;Xu Wen(School of Pharmacy,Shandong University of Traditional Chinese Medicine,Jinan 250355,China;School of Management,Shandong University of Traditional Chinese Medicine,Jinan 250355,China)

机构地区：[1]山东中医药大学药学院,济南250355 [2]山东中医药大学管理学院,济南250355

出　　处：《中国药事》2022年第6期603-610,共8页Chinese Pharmaceutical Affairs

基　　金：山东省中医药科技发展计划项目(编号2019-0006)。

摘　　要：目的:研究我国医药制造业的技术创新效率并分析影响技术创新效率的原因,提出相对应的改进措施。方法:选用两阶段数据包络分析(Data Envelopment Analysis,DEA)方法将技术创新过程分为技术研发和技术转化2个阶段,测算我国医药制造业的技术创新效率值。结果:我国医药制造业全国平均综合效率值以及四大经济区域的综合效率值在技术研发和技术转化阶段均未达到DEA有效状态,综合效率的提升主要受纯技术效率的影响,其次技术研发和技术转化阶段中全国仅有少数省份达到了DEA有效状态,资源存在投入冗余和不足的现象。结论:医药制造业应注重提高企业的管理水平和创新能力,同时应根据不同地区不同省份的实际情况,合理规划技术创新过程中资源的投入规模和投入方向,有效提升行业技术创新效率。Objective: To study the technological innovation efficiency of pharmaceutical manufacturing industry in China and analyze the reasons infl uencing the technological innovation e ffi ciency, so as to put forward corresponding improvement measures. Methods: Two-stage data envelopment analysis(DEA) was used to divide the technological innovation process into two stages: technological research and development and technological transformation. The technological innovation e ffi ciency of pharmaceutical manufacturing industry in China was calculated. Results: The national average overall efficiency value of medicine manufacturing industry in our country and comprehensive e ffi ciency value of four economic regions in technology research and development and technical transformation stage failed to meet the DEA valid state. The improvement of comprehensive e ffi ciency is mainly influenced by pure technical efficiency. In addition, only a few provinces reached the DEA valid state in technology research and development and technical transformation, and there were input redundant and insu ffi cient resources. Conclusion: The pharmaceutical manufacturing industry should pay attention to improving the management level and innovation abilities of enterprises. Meanwhile, according to the actual situation of dif ferent regions and provinces, it is suggested to reasonably plan resource investment scale and direction in the process of technological innovation and effectively improve the efficiency of technological innovation in the industry.

关 键 词：医药制造业 两阶段数据包络分析 技术研发 技术转化 创新效率 

分 类 号：R95[医药卫生—药学]